Objective of this report is to present and review the clinical effectivenes
s and safety of corticosteroids in the treatment of patients with acute spi
nal cord injury The analysis comprises randomised, controlled clinical tria
ls of corticosteroids in acute spinal cord injury, such as the US multicent
er National Acute Spinal Cord Injury Studies (NASCIS) I - III, and investig
ations with historical patient control groups in comparison to corticostero
id-treated patients.
Only NASCIS-II was able to demonstrate a better 1-year motor recovery (acco
rding to neurologic change scores) subsequent to application of high-dose m
ethylprednisolone (MPS) (dosage: 30 mg/kg body weight (BW) on admission fol
lowed by 5.4 mg/kg BW/h continuous 23 h-infusion) in those patients, who ha
d been treated within 8 h after acute injury The analysed studies demonstra
ted that a further increase in the dose of the corticosteroid applied or a
prolongation of its application did not result in better spinal recovery On
the contrary increasing corticosteroid doses were associated with an enhan
ced rate of septic complications and a higher incidence of pneumonia, There
was no difference in the 1-year morbidity or mortality between patients tr
eated with or without corticosteroids, Neurological recovery of spinal func
tions, general patient outcome and prognosis did not differ in patients irr
espective of therapy with corticosteroids.
This review of randomised, prospective trials of corticosteroids in acute s
pinal cord injuries and subsequent studies with historical controls shows t
hat there remain considerable uncertainties about their clinical effectiven
ess. There is controversy in the available studies' data and the statistica
l analyses performed. There are concerns about unclear functional-neurologi
cal end points, potentially serious treatment-associated side effects and t
he lack of proof for valid clinical benefits. Therefore, to include cortico
steroids in the medical management of acute spinal cord injury remains the
individual decision of the physician responsible for treatment.